WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Policy Brief (2015)
Download
New recommendation
Oral PrEP containing tenofovir disoproxil fumarate (TDF) should be offered as an additional prevention choice for people at substantial risk of HIV infection as part of combination HIV prevention approaches.
